Linezolid Pfizer

Linezolid, the active ingredient in Linezolid Pfizer, is a oxazolidinone antibiotic presented as an injectable solution for intravenous use. It treats infections caused by susceptible Gram‑positive bacteria, including MRSA and VRE, in adult patients.

GNH USA supplies Linezolid Pfizer as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

Linezolid is an oxazolidinone antibiotic used to treat serious Gram‑positive bacterial infections. - Skin and soft tissue infections: effective against MRSA and other susceptible Gram‑positive organisms. - Hospital‑acquired pneumonia: treats infections caused by susceptible Gram‑positive bacteria. - Complicated urinary tract infections: provides antibacterial activity against resistant Gram‑positive pathogens.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools occurring during therapy. - Headache: transient cranial discomfort. - Vomiting: occasional emesis. - Metallic taste: altered taste perception. - Rash: mild skin erythema.

Serious or Rare Side Effects: - Thrombocytopenia: significant drop in platelet count. - Peripheral neuropathy: nerve damage causing tingling or numbness. - Serotonin syndrome: potentially life‑threatening reaction when combined with serotonergic agents. - Lactic acidosis: accumulation of lactate leading to metabolic disturbance. - Optic neuritis: inflammation of the optic nerve affecting vision. - Severe hypotension: marked drop in blood pressure.

Linezolid requires careful monitoring in several clinical situations. - Renal impairment: monitor renal function and adjust therapy as needed. - Hepatic dysfunction: assess liver enzymes regularly. - Concomitant serotonergic agents: avoid due to risk of serotonin syndrome. - Prolonged therapy: perform periodic blood count checks. - Pregnancy and lactation: use only when benefits outweigh potential risks. - Store at ambient temperature: keep in original container, protect from moisture and light.

Linezolid can interact with several drug classes. Major Interactions (Avoid): - Selective serotonin reuptake inhibitors (SSRIs): increased risk of serotonin syndrome. - Monoamine oxidase inhibitors (MAOIs): heightened serotonin toxicity. - Tyramine‑rich foods: may cause hypertensive crisis. Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR and bleeding risk. - Phenytoin: may reduce linezolid plasma concentrations. - Rifampin: may decrease linezolid efficacy through enzyme induction.